PMID: 12774524May 31, 2003Paper

Perspective of standardization of surgical treatment for hepatocellular carcinoma

Nihon Geka Gakkai zasshi
Shigeki Arii

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignancies in Japan and worldwide. In recent years, surgical treatment for this disease has made great progress, leading to reduced operative morbidity and mortality. The advances have made it feasible to standardize surgical treatment. Moreover, the public deserves quality treatment ensured by surgical expertise. In these circumstances, the author believes that the following are important issues in the standardization of surgical therapy. 1) Surgical indications and evaluation of hepatic functional reserve, for which the Makuuchi criteria appear useful in principle, must be standardized. 2) The surgical method must be determined. Anatomically systematized resection may be reasonable, although nonanatomical resection may be performed when resection of less extent than the Healey segment is performed. 3) A consensus must be reached on pre- and postoperative adjuvant chemotherapy. Interferon administration liver transplantation may be a promising prophylactic therapy against hepatitis C-related HCC recurrence after curative resection. 4) It is necessary to clarify the long-term survival rate of patients with small HCC who undergo radiofrequency ablation in relation to tum...Continue Reading

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.